UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$1.21B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$855M |
| 3 |
Microsoft
MSFT
|
+$810M |
| 4 |
Advanced Micro Devices
AMD
|
+$805M |
| 5 |
Boeing
BA
|
+$739M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$561M |
| 2 |
Amneal Pharmaceuticals
AMRX
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$161M |
| 4 |
Unity
U
|
+$158M |
| 5 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.49% |
| 2 | Financials | 9.06% |
| 3 | Consumer Discretionary | 7.01% |
| 4 | Healthcare | 6.25% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4801
Fate Therapeutics
FATE
$326M
| $1.82M | ﹤0.01% |
1,103,393
+699,114
| +173% | +$1.76M |
|
4802
CALL
ResMed
RMD
$30.7B
| $1.82M | ﹤0.01% |
7,950
-250
| -3% | -$60.2K |
|
4803
Direxion Daily Regional Banks Bull 3X ETF
DPST
$391M
| $1.82M | ﹤0.01% |
16,548
+16,231
| +5,120% | +$2.02M |
|
4804
BioCryst Pharmaceuticals
BCRX
$2.4B
| $1.81M | ﹤0.01% |
240,352
-184,667
| -43% | -$1.4M |
|
4805
Pediatrix Medical
MD
$2.2B
| $1.81M | ﹤0.01% |
137,702
+74,668
| +118% | +$1.03M |
|
4806
PUT
Alerian MLP ETF
AMLP
$13.1B
| $1.81M | ﹤0.01% |
+37,500
| New | +$1.8M |
|
4807
Viant Technology
DSP
$265M
| $1.8M | ﹤0.01% |
94,990
+76,920
| +426% | +$1.2M |
|
4808
Eton Pharmaceutcials
ETON
$1.22B
| $1.8M | ﹤0.01% |
135,352
+116,335
| +612% | +$1.18M |
|
4809
SI-BONE Inc
SIBN
$834M
| $1.8M | ﹤0.01% |
128,569
+109,094
| +560% | +$1.47M |
|
4810
Invesco S&P 500 Equal Weight Consumer Discretionary ETF
RSPD
$338M
| $1.8M | ﹤0.01% |
33,719
-1,036
| -3% | -$55.4K |
|
4811
Codere Online
CDRO
$408M
| $1.8M | ﹤0.01% |
278,861
+157,098
| +129% | +$1.21M |
|
|
GRMN
4812
CALL
Garmin
GRMN
$60B
| $1.8M | ﹤0.01% |
8,720
+8,000
| +1,111% | +$1.57M |
|
4813
PUT
Vornado Realty Trust
VNO
$7.38B
| $1.8M | ﹤0.01% |
+42,700
| New | +$1.81M |
|
|
SWI
4814
DELISTED
SolarWinds Corporation Common Stock
SWI
| $1.79M | ﹤0.01% |
125,959
+20,293
| +19% | +$274K |
|
4815
Virgin Galactic
SPCE
$398M
| $1.79M | ﹤0.01% |
305,009
+292,895
| +2,418% | +$1.95M |
|
4816
CALL
Zoetis
ZTS
$30B
| $1.79M | ﹤0.01% |
11,000
| – | – |
|
4817
Hamilton Insurance Group
HG
$3.56B
| $1.79M | ﹤0.01% |
94,054
+68,766
| +272% | +$1.27M |
|
|
PML
4818
PIMCO Municipal Income Fund II
PML
$493M
| $1.79M | ﹤0.01% |
220,821
-75,541
| -25% | -$664K |
|
4819
Movado Group
MOV
$841M
| $1.78M | ﹤0.01% |
90,473
+46,301
| +105% | +$908K |
|
4820
PUT
Box
BOX
$4.6B
| $1.78M | ﹤0.01% |
+56,300
| New | +$1.85M |
|
4821
Gladstone Capital
GLAD
$446M
| $1.78M | ﹤0.01% |
62,532
+46,591
| +292% | +$1.21M |
|
4822
Apogee Enterprises
APOG
$908M
| $1.78M | ﹤0.01% |
24,861
+2,440
| +11% | +$192K |
|
4823
National Healthcare
NHC
$3.38B
| $1.77M | ﹤0.01% |
16,485
+7,828
| +90% | +$952K |
|
4824
Evolution Petroleum
EPM
$131M
| $1.77M | ﹤0.01% |
338,863
+307,738
| +989% | +$1.68M |
|
|
DCBO
4825
Docebo
DCBO
$566M
| $1.77M | ﹤0.01% |
39,572
+10,532
| +36% | +$497K |
|
Similar funds
UBS Group's Q4 2024 Portfolio in Review
As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.
- UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
- UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
- UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
- UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
- UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
- UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.